Ryne Biotechnology Funding & Investors

San Diego, CA

Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States.

Total Amount Raised: $89,000,000

Ryne Biotechnology Funding Rounds

Series A
$82,000,000
Feb 28, 2024
Series A Investors
Alaska Permanent Fund
Cure Ventures
Column Group
Euclidean Capital
Saisei Ventures
Grant
$4,000,000
Feb 13, 2023
Grant Investors
California Institute for Regenerative Medicine
Seed
$3,000,000
Jul 19, 2022
Seed Investors
Saisei Ventures

Funding info provided by Diffbot.